tiprankstipranks
Trending News
More News >

Bio-Gene Technology Raises $2.45 Million Through Share Purchase Plan

Story Highlights
Bio-Gene Technology Raises $2.45 Million Through Share Purchase Plan

Don’t Miss TipRanks’ Half-Year Sale

Bio-Gene Technology Ltd. ( (AU:BGT) ) just unveiled an announcement.

Bio-Gene Technology Limited announced the results of its 2025 Share Purchase Plan (SPP), raising $338,500 through the issuance of 14,717,362 fully paid ordinary shares. This, combined with a previous placement, brings the total capital raised to $2.45 million. The funds will support various initiatives, including Flavocide® regulatory studies, Qcide® scale-up, product development, and commercial partnerships. The SPP shares will be issued on 3 June 2025, with trading expected to commence on 4 June 2025, and they will rank equally with existing ordinary shares.

More about Bio-Gene Technology Ltd.

Bio-Gene Technology Limited is an Australian company specializing in the development of novel bio-insecticides aimed at addressing global challenges such as insecticide resistance and toxicity. The company’s unique products, based on naturally occurring compounds, are designed to control pests with minimal impact on human health and the environment. Bio-Gene’s products have applications in public health, crop protection, grain storage, and consumer use, providing effective and safe pest management solutions.

Average Trading Volume: 166,480

Technical Sentiment Signal: Sell

Current Market Cap: A$5.54M

Find detailed analytics on BGT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1